Biosino Bio-Technology and Science Incorporation (HKG:8247)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.770
+0.030 (0.80%)
At close: Mar 27, 2026
Market Cap545.55M +585.5%
Revenue (ttm)246.61M -20.7%
Net Income-51.86M
EPS-0.36
Shares Out144.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume86,000
Average Volume271,500
Open3.740
Previous Close3.740
Day's Range3.740 - 3.860
52-Week Range0.260 - 7.000
Beta-0.04
RSI36.74
Earnings DateMar 31, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a a strategic cooperation agreeme... [Read more]

Sector Healthcare
Founded 1988
Employees 471
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8247
Full Company Profile

Financial Performance

In 2024, HKG:8247's revenue was 263.07 million, a decrease of -9.00% compared to the previous year's 289.07 million. Losses were -42.53 million, 265.1% more than in 2023.

Financial numbers in CNY Financial Statements